New hypnotics;Neue Schlafmittel: Zopiclon und Zolpidem

Aktuelle Neurologie

Volumn 23, Issue 2, 1996, Pages 82-87

  Clarenbach, P ^a  

^a Evangelisches Johanneskrankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT; ZOLPIDEM; ZOPICLONE;

AMNESIA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HANGOVER; HUMAN; INSOMNIA; NEUROTOXICITY; PSYCHOSIS; REVIEW; SIDE EFFECT;

EID: 0029973506     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017838     Document Type: Article

References (55)

1. Ahmad, Z., M. Herepath, P. Ebden: Diagnostic utility of flumazenil in coma with suspected poisoning. Brit. Med. J. 302 (1991) 292
2. Ahrens, J.: Behandlung von Schlafstörungen mit Zolpidem. Wirksamkeit ohne Abhängigkeitspotential. Therapiewoche Schweiz 9 (1993) 660-662
3. Annseau, M., W. Pitchot, M. Hansenne et al.: Psychotic reactions to zolpidem. Lancet 339 (1992) 809
4. Berlin, I., D. Warot, T. Herguet et al.: Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J. Clin. Psychopharmacol. 13 (1993) 100-106
5. Biggio, G., A. Concas, M. G. Gorda et al.: Enhancement of GABAergic transmission by zolpidem, an imidazopyridine with preferential affinity for type 1 benzodiazepine receptors. Eur. J. Pharmacol. 161 (1989) 173-180
6. Blanchard, J. C., J. L. Zundel, L. Julou: Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepines binding to rat hippocampus photolabelled membranes. Biochem. Pharmacol. 32 (1983) 3651-3653
7. Blois, R., J. M. Gaillard, P. Attali et al.: Effect of zolpidem on sleep in healthy subjects: A placebo-controlled trial with polysomnographic recordings. Clin. Therap. 15 (1993) 787-809
8. Bruun, T. G.: Misbrugspotentiale under brug og abstinenspsykose efter behandling med sovemidlet zolpidem (Stilnoct). Ugeskr. Laeger. 155 (1993) 2711-2712
9. Cavallaro, R., M. G. Reggazetti, E. Smeraldi: Tolerance and withdrawal with zolpidem. Lancet 342 (1992) 374-375
10. Clarenbach, P., W. Fischer: Nachtschlaf und Tagesbefinden schlafgestörter Patienten unter Zopiclon. Eine Anwendungsbeobachtung. Psychopharmakoth. 2 (1995) 6-11
11. Clarenbach, P., R. Steinberg, H. G. Weeß et al.: Empfehlungen zu Diagnostik und Therapie der Insomie. Deutsche Gesellschaft für Schlafforschung und Schlafmedizin DGSM. Nervenarzt 66 (1995) 723-729
12. Cluydts, R. J., J. M. De Roeck, A. M. Jolie: A three week multicenter general practitioner study of zolpidem in 651 patients with insomnia. Acta Therap. 19 (1993) 73-91
13. Cohn, M. A.: Effects of zolpidem, codein phosphate and placebo on respiration. A double-blind crossover study in volunteers. Drug Safety 9 (1993) 312-319
14. Dorian, P., E. M. Sellers, H. Kaplan et al.: Evaluation of zopiclone physical dependence liability in normal volunteers. Pharmacology 27, Suppl. 2 (1983) 228-234
15. Fleming, J. A. E., J. Bourgouin, P. Hamilton: A sleep laboratory evaluation of the longterm efficacy of zopiclone. Can. J. Psychiatry 33 (1988) 103-107
16. Gericke, C. A., A. C. Ludolph: Chronic abuse of zolpidem. J. Amer. Med. Assoc. 22 (1994) 272
17. Goa, K. L., R. C. Heel: Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 32 (1986) 48-65
18. Griffiths, R. K., C. A. Sannerud, N. A. Ator et al.: Zolpidem behavioral pharmacology in baboons: self injection, discrimination, tolerance and withdrawal. J. Pharmacol. Exp. Ther. 260 (1993) 1199-1208
19. Hajak, G., P. Clarenbach, W. Fischer et al.: Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. Int. Clin. Psychopharmacol. 9 (1994) 251-261
20. Herrmann, W. R., St. Kubicki, S. Boden et al.: Pilot controlled double blind study of the hypnotic effects of zolpidem in patients with chronic "learned" insomnia: Psychometric and polysomnographic evaluation. J. Intern. Med. Res. 21 (1993) 306-322
21. Hindmarch, I., H. On: Benzodiazepine receptor ligands, memory and information processing: issues, comments and prospects. In: Hindmarch, I., H. Ott: Benzodiazepine Receptor Ligands: Memory and Information Processing. Psychometric, Psychopharmacological and Clinical Issues. Psychopharmacol. Series 6, Springer Verlag, Heidelberg (1988) 227-284
22. Hoehns, J. D., P. J. Perry: Zolpidem: A nonbenzodiazepine hypnotic for treatment of insomnia. Clin. Pharm. 12 (1993) 814-828
23. Inman, W., K. Kubota, G. Pearce et al.: PEM Report Number 10. Zopiclone. Pharmaco-epidemiology and Drug Safety 2 (1993) 499-521
24. Klimm, H. D., J. F. Dreyfus, M. Delmotte: Zopiclone versus nitrazepam: A douple-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 10, Suppl. 1 (1987) 73-78
25. Kummer, J., L Gündel: Behandlung von Schlafstörungen im Alter mit Zolpidem. Fortschr. Ther. 112 (1994) 344-346
26. Lader, M., S. C. Denney: A double blind study to establish the residual effects of zopiclone on performance in healthy volunteers. Pharmacology 27 (1983) 98-108
27. Lader, M. G. Fracka: Subjective effects during and on discontinuation of zopiclone and temazepam in normal subjects. Pharmacopsychiatry 20 (1987) 67-71
28. Langer, S. Z., S. Arbilla: Imidazophyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omegareceptor subtypes. Pharmacol. Biochem. Behav. 29 (1988) 763-766
29. Mamelak, M., A. Scima, V. Price: Effects of zopiclone on the sleep of chronic insomniacs. Pharmacology 27, Suppl. 2 (1983) 156-164
30. McCann, C. C., M. A. Quera-Salva, J. Bodet et al.: Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects. Fundam. Clin. Pharmacol. 7 (1993) 305-310
31. Mereu, G., G. Carcangui, A. Concas et al.: Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type 1 benzodiazepine receptors. Eur. J. Pharmacol. 179 (1990) 339-346
32. Monti, J. M., P. Attali, D. Monti et al.: Zolpidem and rebound insomnia - a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatr. 27 (1994) 166175
33. Morselli, P. L., J. Larribaud, Ph. Guillet et al.: Daytime residual effects of zolpidem: a review of available data. In: J. P. Sauvanet, S. Z. Langer, P. L. Morselli (eds.): Imidazopyridines in Sleep Disorders. Raven Press, New York (1988) 183-191
34. Mouret, J., D. Ruel, F. Maillard et al.: Zopiclone vs. triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. Int. J. Clin. Psychopharmacol. 5, Suppl. 2 (1990) 47-55
35. Müller, W. E.: Zopiclon. Unterschiede und Gemeinsamkeiten zu Benzodiazepin-Hypnotika. Arzneimitteltherapie 9 (1991) 301-303
36. Müller, W. E.: Wie "neu" sind die neuen Hypnotika Zopiclon und Zolpidem? Arzneiverordnung in der Praxis 2 (1994) 6-8
37. Nicholson, A. N., B. M. Stone: Efficacy of zopiclone in middle age. Sleep 10, Suppl. 1 (1987) 35-39
38. Petre-Quadens, O., G. Huffman, G. Buytaert: Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age. Pharmacology 27, Suppl. 2 (1983) 146-155
39. Pull, C. B., J. F. Dreyfus, J. P. Brun: Comparison of nitrazepam and zopiclone in psychiatric patients. Pharmacology 27 (1983) 205-209
40. Quera-Salva, M. A., C. McCann, J. Boudet et al.: Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorors. Br. J. Clin. Pharmacol. 37 (1994) 539-543
41. Richens, A., A. J. Mercer, D. M. Jones et al.: Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers. Br. J. clin. Pharmacol. 36 (1993) 61-65
42. Roger, M., P. Attali, J. P. Coquelin: Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia: Clin. Therap. 15 (1993) 127-136
43. Scharf, M. B., T. Roth, G. W. Vogel et al.: A multicenter, placebocontrolled study evaluating zolpidem in the treatment of chronic insomnia. J. Clin. Psychiatry 55 (1994) 192-199
44. Schulz, H., M. Jobert, P. Jähning: Macroo- and microstructure of sleep in insomniac patients under the influence of a benzodiazepine and non-benzodiazepine hypnotic. In: Raccagni, G. (ed.): Biological Psychiatry. Elsevier Science Publishers, Amsterdam (1991) 823-826
45. Sicard, B. A., S. Trocjerie, J. Moreau et al.: Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots. Aviat. Space Environm. Med. 64 (1993) 371-375
46. Tammimen, T., P. Hansen: Chronic administration of zopiclone and nitrazepam in the treatment of insomnia. Sleep 10, Suppl. 1 (1987) 63-72
47. Thakore, J., T. G. Dinan: Physical dependence following zopiclone usage: A case report. Human Psychopharmacol. 7 (1992) 143-145
48. Thome, J., M. Ruchsow, M. Rosier et al.: Zolpidem-Abhängigkeit und Depression im Senium. Psychiatr. Prax. 22 (1995) 165-166
49. Tiberge, M., U. Calvet, N. Khayi et al.: Comparison des effets de la zopiclone et du triazolam sur le sommeil du sujet sain. L'Encephale 14 (1988) 319-324
50. Trachsel, L., D. J. Dijk, D. Brunner et al.: Effect of zopiclone and midazolam on sleep and EEC spectrum in a phase-advanced sleep schedule, Neuropsychopharmacol. 3 (1990) 11-18
51. Trifiletti, R., S. Snyder: Anxiolytic cyclopyrrolones suriclone and zopiclone bind to a novel site linked allosterically to benzodiazepine receptors. Mol. Pharmacol. 26 (1984) 458-469
52. Weintraub, M., S. Singh, L. Byrne et al.: Consequences of the 1989 New York state triplicate benzodiazepine prescription regulations. J. Amer. Med. Assoc. 266 (1991) 2392-2397
53. Wheatley, D.: Zolpidem and Placebo: A study in general practice in patients suffering from insomnia. In: J. P. Sauvanet, S. Z. Langer, P. L. Morselli (eds.): Imidazopyridines in Sleep Dosorders. Raven Press, New York (1988) 305-316
54. Wildschiodtz, G., B. Gynning: The effect of zopiclone on sleep in patients with mild sleep apnea. WFSRS Founding Congress, Cannes (1991) Abstr. 184
55. Yanagita, T.: Dependence potential of zopiclone studied in monkeys. Pharmacology 27, Suppl. 2 (1983) 216-227